Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2025-12-24 @ 1:18 PM
NCT ID:
NCT01114295
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting with signs and symptoms of "overt, obscure GI bleeding" including hematemesis, melena, and hematochezia within the past 14 days with negative endoscopic evaluation (including upper endoscopy for hematemesis, and both upper and lower endoscopy for hematochezia) despite clinical evidence of GI bleeding.
Exclusion Criteria:
* Known renal insufficiency (or blood Creat \>1.5 or estimated glomerular filtration rate \[eGFR\]\<60)
* Allergy to iodinated intravenous (IV) contrast media
* Swallowing difficulties
* Known small bowel strictures
* Suspected bowel obstruction
* Under the age of 18
* Unable to give consent
* Currently pregnant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01114295
Study Brief:
Protocol Section:
NCT01114295